BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 28373452)

  • 1. Chemoembolization with Drug-eluting Microspheres Loaded with Doxorubicin for the Treatment of Cholangiocarcinoma.
    Aliberti C; Carandina R; Sarti D; Pizzirani E; Ramondo G; Mulazzani L; Mattioli GM; Fiorentini G
    Anticancer Res; 2017 Apr; 37(4):1859-1863. PubMed ID: 28373452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoembolization (TACE) of unresectable intrahepatic cholangiocarcinoma with slow-release doxorubicin-eluting beads: preliminary results.
    Aliberti C; Benea G; Tilli M; Fiorentini G
    Cardiovasc Intervent Radiol; 2008; 31(5):883-8. PubMed ID: 18478290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoembolization Adopting Polyethylene Glycol Drug-Eluting Embolics Loaded With Doxorubicin for the Treatment of Hepatocellular Carcinoma.
    Aliberti C; Carandina R; Sarti D; Mulazzani L; Pizzirani E; Guadagni S; Fiorentini G
    AJR Am J Roentgenol; 2017 Aug; 209(2):430-434. PubMed ID: 28537756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy.
    Kuhlmann JB; Euringer W; Spangenberg HC; Breidert M; Blum HE; Harder J; Fischer R
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):437-43. PubMed ID: 22261548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-eluting beads transarterial chemoembolization by CalliSpheres is effective and well tolerated in treating intrahepatic cholangiocarcinoma patients: A preliminary result from CTILC study.
    Luo J; Zheng J; Shi C; Fang J; Peng Z; Huang J; Sun J; Zhou G; Li T; Zhu D; Xu H; Hou Q; Ying S; Sun Z; Du H; Xie X; Cao G; Ji W; Han J; Gu W; Guo X; Shao G; Yu Z; Zhou J; Yu W; Zhang X; Li L; Hu H; Hu T; Wu X; Chen Y; Ji J; Hu W
    Medicine (Baltimore); 2020 Mar; 99(12):e19276. PubMed ID: 32195932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comments on "Chemoembolization (TACE) of unresectable intrahepatic cholangiocarcinoma with slow-release doxorubicin-eluting beads: preliminary results".
    Kim JH
    Cardiovasc Intervent Radiol; 2010 Feb; 33(1):226. PubMed ID: 19533225
    [No Abstract]   [Full Text] [Related]  

  • 7. Transarterial chemoembolization (TACE) for inoperable intrahepatic cholangiocarcinoma.
    Herber S; Otto G; Schneider J; Manzl N; Kummer I; Kanzler S; Schuchmann A; Thies J; Düber C; Pitton M
    Cardiovasc Intervent Radiol; 2007; 30(6):1156-65. PubMed ID: 17508242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoembolization with drug eluting beads preloaded with irinotecan (DEBIRI) vs doxorubicin (DEBDOX) as a second line treatment for liver metastases from cholangiocarcinoma: a preliminary study.
    Venturini M; Sallemi C; Agostini G; Marra P; Cereda S; Reni M; Aldrighetti L; De Cobelli F; Del Maschio A
    Br J Radiol; 2016 Nov; 89(1067):20160247. PubMed ID: 27558984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoembolization with Degradable Starch Microspheres for Treatment of Patients with Primary or Recurrent Unresectable, Locally Advanced Intrahepatic Cholangiocarcinoma: A Pilot Study.
    Goerg F; Zimmermann M; Bruners P; Neumann U; Luedde T; Kuhl C
    Cardiovasc Intervent Radiol; 2019 Dec; 42(12):1709-1717. PubMed ID: 31578633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for unresectable hepatic tumors.
    Poggi G; Quaretti P; Minoia C; Bernardo G; Bonora MR; Gaggeri R; Ronchi A; Saluzzo CM; Azzaretti A; Rodolico G; Montagna M; Amatu A; Teragni C; Palumbo I; Traverso E; Tonini S; Villani L; Scelsi M; Baiardi P; Felisi MG; Sottotetti F; Tagliaferri B; Riccardi A
    Anticancer Res; 2008; 28(6B):3835-42. PubMed ID: 19192637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results.
    de Baere T; Deschamps F; Teriitheau C; Rao P; Conengrapht K; Schlumberger M; Leboulleux S; Baudin E; Hechellhammer L
    J Vasc Interv Radiol; 2008 Jun; 19(6):855-61. PubMed ID: 18503899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma: a multi-institutional analysis.
    Hyder O; Marsh JW; Salem R; Petre EN; Kalva S; Liapi E; Cosgrove D; Neal D; Kamel I; Zhu AX; Sofocleous CT; Geschwind JF; Pawlik TM
    Ann Surg Oncol; 2013 Nov; 20(12):3779-86. PubMed ID: 23846786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience.
    Gusani NJ; Balaa FK; Steel JL; Geller DA; Marsh JW; Zajko AB; Carr BI; Gamblin TC
    J Gastrointest Surg; 2008 Jan; 12(1):129-37. PubMed ID: 17851723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conventional and drug-eluting beads transarterial chemoembolization in patients with unresectable intrahepatic cholangiocarcinoma: a systematic review and pooled analysis.
    He M; Jiang N; Yin X; Xu A; Mu K
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):531-540. PubMed ID: 36402872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxaliplatin-eluting microspheres for the treatment of intrahepatic cholangiocarcinoma: a case report.
    Poggi G; Quaretti P; Minoia C; Palumbo I; Villani L; Amatu A; Teragni C; Scelsi M; Zappoli F; Bernardo G
    Anticancer Res; 2008; 28(5B):2987-90. PubMed ID: 19031944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response rate and safety in patients with hepatocellular carcinoma treated with transarterial chemoembolization using 40-µm doxorubicin-eluting microspheres.
    Albrecht KC; Aschenbach R; Diamantis I; Eckardt N; Teichgräber U
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):23-32. PubMed ID: 32880029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution.
    Burger I; Hong K; Schulick R; Georgiades C; Thuluvath P; Choti M; Kamel I; Geschwind JF
    J Vasc Interv Radiol; 2005 Mar; 16(3):353-61. PubMed ID: 15758131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics.
    Varela M; Real MI; Burrel M; Forner A; Sala M; Brunet M; Ayuso C; Castells L; Montañá X; Llovet JM; Bruix J
    J Hepatol; 2007 Mar; 46(3):474-81. PubMed ID: 17239480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locally advanced intrahepatic cholangiocarcinoma successfully resected after transcatheter arterial chemoembolization with degradable starch microspheres: report of a case.
    Wu Y; Saiura A; Yamamoto J; Koga R; Asahara S; Kamei A; Takano K; Ikari T; Seki M; Yamaguchi T; Muto T
    Hepatogastroenterology; 2007; 54(77):1345-7. PubMed ID: 17708251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic Arterial Infusion of Polyethylene Glycol Drug-eluting Beads for Primary and Metastatic Liver Cancer Therapy.
    Aliberti C; Carandina R; Sarti D; Mulazzani L; Catalano V; Felicioli A; Coschiera P; Fiorentini G
    Anticancer Res; 2016 Jul; 36(7):3515-21. PubMed ID: 27354617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.